Petros Grivas, Professor at University of Washington and Fred Hutch, shared an update from Ashish M. Kamat, Associated Editor at European Urology Oncology, on X, adding:
“Fantastic meeting IBCG with stellar colleagues, networking, input from regulators, inspiration from patients, so energized!”
Quoting Ashish M. Kamat:
“I haven’t posted much during IBCG26, as wonderfully busy as it’s been, but I have to post this. IMHO, the most important part of our meeting: the Patient Perspective panel. A reminder of why we are all here.
20 years ago, IBCG started with a small group around a table. Later this month, friends and colleagues from around the world gather in Houston for IBCG26. Two days around the table tackling some of the hardest questions in bladder cancer, debating the evidence and challenging each other on where we go next. Looking forward to seeing you all!”
Ashish M. Kamat was recognized among OncoDaily’s The 100 Most Influential People in Prostate Cancer in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
You might be interested in: FDA Approves Perioperative Pembrolizumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer
